CFDE Data Portal | Search BCLAF1P2

	Label	Description
	BCLAF1P2 Gene (Entity type)	ENSG00000279800 - BCL2 associated transcription factor 1 pseudogene 2
	GSE155031 catechin SH-SY5Y 6 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE118816 Myo1c knockdown podocyte 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE213650 everolimus 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE85880 GSE85881 tretinoin cardiac muscle cell 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Pancreas 20-29 vs 70-79 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Heart 20-29 vs 50-59 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Brain 20-29 vs 70-79 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Heart 20-29 vs 70-79 Down Gene Set (Entity type)	A Gene Set from GTEx
	GSE165334 dabrafenib A-375 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS

BCLAF1P2

ENSG00000279800 - BCL2 associated transcription factor 1 pseudogene 2

GSE155031 catechin SH-SY5Y 6 v 0 human up

A Gene Set from LINCS

GSE118816 Myo1c knockdown podocyte 0 v 3 human up

A Gene Set from LINCS

GSE213650 everolimus 0 v 2 human dn

A Gene Set from LINCS

GSE85880 GSE85881 tretinoin cardiac muscle cell 0 v 2 human up

A Gene Set from LINCS

GTEx Pancreas 20-29 vs 70-79 Up

A Gene Set from GTEx

GTEx Heart 20-29 vs 50-59 Down

A Gene Set from GTEx

GTEx Brain 20-29 vs 70-79 Down

A Gene Set from GTEx

GTEx Heart 20-29 vs 70-79 Down

A Gene Set from GTEx

GSE165334 dabrafenib A-375 3 v 0 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.